OncoMatch/Clinical Trials/NCT06968221
Bovine Reinforcement in Stomach, Colorectal and Lung Operation
Is NCT06968221 recruiting? Yes, currently enrolling (Jun 2026). This Phase 3 trial studies Bioabsorbable Staple Line Reinforcemen for rectal cancer stage iii.
Treatment: Bioabsorbable Staple Line Reinforcemen — The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of stomach,colorectal and lung anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced techniques with respect to the incidence of postoperative hemorrage rate, anastomotic leakage, if applicable.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Other
Cancer type
Colorectal Cancer
Non-Small Cell Lung Carcinoma
Small Cell Lung Cancer
Disease stage
Required: Stage III
Demographics
Lab requirements
Kidney function
creatinine <= 1.6
Liver function
liver enzymes <= 50% upper limit of normal values
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT06968221 currently recruiting?
Yes, this trial is currently recruiting patients.
What disease stage is eligible?
Stage III is required.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify